Daniel Munblit

10.3k total citations · 5 hit papers
83 papers, 3.3k citations indexed

About

Daniel Munblit is a scholar working on Neurology, Epidemiology and Nutrition and Dietetics. According to data from OpenAlex, Daniel Munblit has authored 83 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 21 papers in Epidemiology and 21 papers in Nutrition and Dietetics. Recurrent topics in Daniel Munblit's work include Infant Nutrition and Health (21 papers), Long-Term Effects of COVID-19 (21 papers) and Food Allergy and Anaphylaxis Research (17 papers). Daniel Munblit is often cited by papers focused on Infant Nutrition and Health (21 papers), Long-Term Effects of COVID-19 (21 papers) and Food Allergy and Anaphylaxis Research (17 papers). Daniel Munblit collaborates with scholars based in United Kingdom, Russia and United States. Daniel Munblit's co-authors include Danilo Buonsenso, Piero Valentini, Cristina De Rose, Robert Boyle, John O. Warner, Louise Sigfrid, Antonia Ricchiuto, Dario Sinatti, Angelo Carfì and Margaret O’Hara and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel Munblit

76 papers receiving 3.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterising long COVID: a living systematic review

2021 568 citations Melina Michelen, Lakshmi Manoharan et al. BMJ Global Health profile →
Preliminary evidence on long COVID in children

2021 323 citations Danilo Buonsenso, Daniel Munblit et al. profile →
Treatment of Multisystem Inflammatory Syndrome in Children

2021 196 citations Daniel Munblit et al. profile →
Role of Human Milk Bioactives on Infants' Gut and Immune Health

2021 188 citations Daniel Munblit et al. Frontiers in Immunology profile →
Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study

2023 67 citations Rosa Morello, Cristina De Rose et al. profile →

Peers

Countries citing papers authored by Daniel Munblit

Since Specialization

Citations

This map shows the geographic impact of Daniel Munblit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Munblit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Munblit more than expected).

Fields of papers citing papers by Daniel Munblit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Munblit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Munblit. The network helps show where Daniel Munblit may publish in the future.

Co-authorship network of co-authors of Daniel Munblit

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Munblit. A scholar is included among the top collaborators of Daniel Munblit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Munblit. Daniel Munblit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systematic scoping review of external validation studies of AI pathology models for lung cancer diagnosis 2025 ·npj Precision Oncology ·(unknown), (unknown), (unknown), Jan Lukas Robertus, Oleg Blyuss, Rhian Gabe, Daniel Munblit, Judith Offman	5
2	Clinical and Phenotypic Characteristics of Early-Onset Inflammatory Bowel Disease: A Five-Year Observational Study 2025 ·Children ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), А. S. Tertychnyy, Daniel Munblit, (unknown)	0
3	COFAITH and COMFA: A Collective Roadmap for Past and Future Food Allergy Clinical Trials and Observational Research on Interventions 2024 ·Clinical & Experimental Allergy ·Jennifer L. P. Protudjer, Daniel Munblit, Christian Apfelbacher, Mary Jane Marchisotto, (unknown), (unknown), Pablo Rodríguez del Río, Pasquale Comberiati	0
4	Cross-sectional examination of commercial milk formula industry funding of international, regional and national healthcare professional associations: protocol 2024 ·BMJ Open ·(unknown), (unknown), Daniel Munblit, Alice Fabbri, Quinn Grundy, Lisa Bero, Robert Boyle, Bartosz Helfer	1
5	The search for an optimal tissue‐engineered urethra model for clinical application based on preclinical trials in male animals: A systematic review and meta‐analysis 2024 ·Bioengineering & Translational Medicine ·(unknown), (unknown), Daniel Munblit, А. Yu. Suvorov, Andrey Morozov, Anastasia Shpichka, Petr Glybochko, Peter Timashev, Denis Butnaru	2
6	Long COVID in low-income and middle-income countries: the hidden public health crisis 2023 ·The Lancet ·Waasila Jassat, Luis Felipe Reyes, Daniel Munblit, Janice Caoili, Fernando A. Bozza, Madiha Hashmi, Michael Edelstein, Cheryl Cohen, Carlos Álvarez, Bin Cao	26
7	Allergic diseases as risk factors for Long‐COVID symptoms: Systematic review of prospective cohort studies 2023 ·Clinical & Experimental Allergy ·(unknown), (unknown), (unknown), (unknown), Stefanie Deckert, (unknown), (unknown), Jochen Schmitt, Daniel Munblit, Christian Apfelbacher	7
8	Intranasal analgesia for acute moderate to severe pain in children – a systematic review and meta-analysis 2023 ·BMC Pediatrics ·(unknown), Екатерина Яковлева, Melanie Rae Simpson, Sindre Andre Pedersen, Daniel Munblit, Odd Martin Vallersnes, Bjarne Austad	7
9	Allergic diseases and immunodeficiencies in children, lessons learnt from COVID ‐19 pandemic by 2022: A statement from the EAACI ‐section on pediatrics 2022 ·Pediatric Allergy and Immunology ·Daniel Munblit, Matthew Greenhawt, Helen A. Brough, (unknown), (unknown), (unknown), John O. Warner, Ömer Kalaycı, Anna Šedivá, Eva Untersmayr, Pablo Rodríguez del Río, Marta Vázquez‐Ortiz, Stefania Arasi, Montserrat Álvaro‐Lozano, Sophia Tsabouri, Elena Galli, Burçin Beken, Philippe Eigenmann	8
10	Quality and consistency of clinical practice guidelines on the prevention of food allergy and atopic dermatitis: Systematic review protocol 2022 ·World Allergy Organization Journal ·Agnes Sze Yin Leung, Elizabeth Huiwen Tham, (unknown), Daniel Munblit, Derek K. Chu, Lamia Dahdah, Kiwako Yamamoto‐Hanada, (unknown), (unknown), (unknown), Santiago Martínez, Anne K. Ellis, Leonard Bielory, (unknown), Hugo Van Bever, Dana Wallace, Mimi L.K. Tang, J. Wesley Sublett, Gary Wong	1
11	The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy 2022 ·Journal of Clinical Medicine ·Danilo Buonsenso, (unknown), (unknown), Luigi Vetrugno, Rosa Morello, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cristina De Rose, Daniel Munblit, Louise Sigfrid, Piero Valentini	15
12	Characterising long COVID: a living systematic review breakdown → 2021 ·BMJ Global Health ·Melina Michelen, Lakshmi Manoharan, Natalie Elkheir, Hung‐Yuan Cheng, Andrew Dagens, Claire Hastie, Margaret O’Hara, (unknown), Dania Dahmash, Polina Bugaeva, Ishmeala Rigby, Daniel Munblit, Eli Harriss, Amanda Burls, (unknown), J. T. Scott, Gail Carson, Piero Olliaro, Louise Sigfrid, Charitini Stavropoulou	568
13	Recovery after prolonged ICU treatment in patients with COVID-19 2021 ·The Lancet Respiratory Medicine ·Matteo Parotto, Sheila Nainan Myatra, Daniel Munblit, Alyaa Elhazmi, Otávio T. Ranzani, Margaret S. Herridge	17
14	Legacy of COVID-19 infection in children: long-COVID will have a lifelong health/economic impact 2021 ·Archives of Disease in Childhood ·Daniel Munblit, Frances Simpson, (unknown), Audrey DunnGalvin, Malcolm G. Semple, John O. Warner	18
15	Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate 2021 ·Frontiers in Immunology ·Francesca Mori, Mattia Giovannini, Simona Barni, Rodrigo Jiménez‐Saiz, Daniel Munblit, Benedetta Biagioni, Giulia Liccioli, Lucrezia Sarti, Lucia Liotti, Silvia Ricci, Elio Novembre, Ümit Murat Şahiner, Ermanno Baldo, Davide Caimmi	29
16	Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID‐19 pandemic: A statement from the EAACI‐section on pediatrics 2020 ·Pediatric Allergy and Immunology ·Helen A. Brough, Ömer Kalaycı, Anna Šedivá, Eva Untersmayr, Daniel Munblit, Pablo Rodríguez del Río, Marta Vázquez‐Ortiz, Stefania Arasi, Montserrat Álvaro‐Lozano, Sophia Tsabouri, Elena Galli, Burçin Beken, Philippe Eigenmann	82
17	Excessive Media Consumption About COVID-19 is Associated With Increased State Anxiety: Outcomes of a Large Online Survey in Russia 2020 ·Journal of Medical Internet Research ·Nikita Nekliudov, Oleg Blyuss, (unknown), (unknown), Jon Genuneit, Nikita Sushentsev, (unknown), Pasquale Comberiati, John O. Warner, Gareth Tudor‐Williams, Martin Teufel, Matthew Greenhawt, Audrey DunnGalvin, Daniel Munblit	83
18	Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients 2019 ·British Journal of Cancer ·Oleg Blyuss, Alexey Zaikin, (unknown), Daniel Munblit, Elena M. Kiseleva, (unknown), Stephen W. Duffy, Tatjana Crnogorac‐Jurcevic	43
19	CLINICAL AND EPIDEMIOLOGICAL ASPECTS OF PRIMARY IMMUNODEFICIENCY DISEASES (PID) AND EARLY DIAGNOSIS OPTIONS 2017 ·Medical Immunology (Russia) ·(unknown), (unknown), Daniel Munblit, И. Г. Козлов, А.П. Продеус, (unknown)	5
20	Breast-Milk Characteristics Protecting Against Allergy 2014 ·Endocrine Metabolic & Immune Disorders - Drug Targets ·(unknown), Pasquale Comberiati, Daniel Munblit, Giorgio Piacentini, (unknown), (unknown), Attilio Boner, Diego Peroni	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact